ESOPHAGOGASTRIC JUCTION CANCER
Clinical trials for ESOPHAGOGASTRIC JUCTION CANCER explained in plain language.
Never miss a new study
Get alerted when new ESOPHAGOGASTRIC JUCTION CANCER trials appear
Sign up with your email to follow new studies for ESOPHAGOGASTRIC JUCTION CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for advanced cancer patients: JR8603 trial begins
Disease control Recruiting nowThis study tests a new drug called JR8603 in people with advanced solid tumors (like stomach or colorectal cancer) that have not responded to standard treatments. The goal is to find the safest dose and see if the drug can shrink tumors. About 94 adults will take part in this ear…
Matched conditions: ESOPHAGOGASTRIC JUCTION CANCER
Phase: PHASE1 • Sponsor: JiaRay Group • Aim: Disease control
Last updated May 17, 2026 03:11 UTC
-
New hope for esophageal cancer: study tests best Pre-Surgery combo
Disease control Recruiting nowThis study aims to find the best treatment before surgery for esophageal cancer. It compares chemotherapy, chemoradiation, targeted therapy, and immunotherapy in 2000 adults with stage I-IVa disease. The goal is to improve survival and reduce side effects.
Matched conditions: ESOPHAGOGASTRIC JUCTION CANCER
Phase: PHASE3 • Sponsor: Cancer Institute and Hospital, Chinese Academy of Medical Sciences • Aim: Disease control
Last updated May 07, 2026 18:43 UTC